BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12071429)

  • 21. Metabolic effects of rhIGF-1 in normal human subjects.
    Rennert NJ; Boulware SD; Kerr D; Caprio S; Tamborlane WV; Sherwin RS
    Adv Exp Med Biol; 1993; 343():311-8. PubMed ID: 8184741
    [No Abstract]   [Full Text] [Related]  

  • 22. rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery.
    Mauras N; Martha PM; Quarmby V; Haymond MW
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E628-33. PubMed ID: 9142884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of non-invasive and implanted telemetric measurement of blood pressure and electrocardiogram in conscious beagle dogs.
    Ward G; Milliken P; Patel B; McMahon N
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):106-13. PubMed ID: 22525003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I; Fabien N; Thivolet C
    Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study.
    Hansen-Pupp I; Hellström A; Hamdani M; Tocoian A; Kreher NC; Ley D; Hallberg B
    Growth Horm IGF Res; 2017 Oct; 36():44-51. PubMed ID: 28934640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.
    Clark RG; Mortensen D; Reifsynder D; Mohler M; Etcheverry T; Mukku V
    Growth Regul; 1993 Mar; 3(1):50-2. PubMed ID: 7683530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.
    Mauras N; Beaufrere B
    J Clin Endocrinol Metab; 1995 Mar; 80(3):869-74. PubMed ID: 7533772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog.
    Taylor GL; Patel B; Sullivan AT
    J Pharmacol Toxicol Methods; 2007; 56(2):212-7. PubMed ID: 17582788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile.
    Quattrin T; Thrailkill K; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Giltinan D; Gesundheit N; Martha P
    Diabetes Care; 1997 Mar; 20(3):374-80. PubMed ID: 9051390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
    Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.
    Narusawa K; Nakamura T; Suzuki K; Matsuoka Y; Lee LJ; Tanaka H; Seino Y
    J Bone Miner Res; 1995 Dec; 10(12):1853-64. PubMed ID: 8619365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective effect of glucose-insulin-potassium solutions in myocardial damage caused by emetine].
    de Micheli A; Medrano GA; Villarreal A; Sodi-Pallares D
    Arch Inst Cardiol Mex; 1975; 45(4):469-86. PubMed ID: 1101837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat.
    Donath MY; Zierhut W; Gosteli-Peter MA; Hauri C; Froesch ER; Zapf J
    Eur J Endocrinol; 1998 Jul; 139(1):109-17. PubMed ID: 9703387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.
    Hartman ML; Clayton PE; Johnson ML; Celniker A; Perlman AJ; Alberti KG; Thorner MO
    J Clin Invest; 1993 Jun; 91(6):2453-62. PubMed ID: 8514857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect sensing of insulin-induced hypoglycaemia by the carotid body in the rat.
    Bin-Jaliah I; Maskell PD; Kumar P
    J Physiol; 2004 Apr; 556(Pt 1):255-66. PubMed ID: 14742728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients.
    Fouque D; Peng SC; Kopple JD
    Kidney Int; 1995 Mar; 47(3):876-83. PubMed ID: 7752587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.